Showing 321-340 of 498 for: Cochrane Systematic Reviews > Neurologic 
- Omega 3 fatty acid for the prevention of cognitive decline and dementia
Cochrane Systematic Reviews, 14-Aug-2012
Evidence from observational studies suggests that diets high in omega-3 long-chain polyunsaturated fatty acids (PUFA) may protect people from cognitive decline and dementia. The strength of this potential protective effect has recently been tested in rand
- Opioid switching to improve pain relief and drug tolerability
Cochrane Systematic Reviews, 27-Nov-2015
Patients with cancer, and increasingly chronic non-cancer pain frequently require strong opioids for pain relief. Morphine is the first-line strong opioid of choice for these patients. While most achieve adequate analgesia with morphine, a significant min
- Opioids for neuropathic pain
Cochrane Systematic Reviews, 29-Aug-2013
This is an updated version of the original Cochrane review published in Issue 3, 2006, which included 23 trials. The use of opioids for neuropathic pain remains controversial. Studies have been small, have yielded equivocal results, and have not establish
- Opioids for the management of breakthrough pain in cancer patients
Cochrane Systematic Reviews, 12-Oct-2015
This review is an update of a previously published review in the Cochrane Database of Systematic Reviews (Issue 1, 2006). Breakthrough pain is a transient exacerbation of pain that occurs either spontaneously or in relation to a specific predictable or un
- Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children
Cochrane Systematic Reviews, 4-Oct-2016
Apnoea is a breathing disorder marked by the absence of airflow at the nose or mouth. In children, risk factors include adenotonsillar hypertrophy, obesity, neuromuscular disorders and craniofacial anomalies. The most common treatment for obstructive slee
- Oral appliances for obstructive sleep apnoea
Cochrane Systematic Reviews, 25-Jan-2006
Obstructive sleep apnoea-hypopnoea (OSAH) is a syndrome characterised by recurrent episodes of partial or complete upper airway obstruction during sleep that are usually terminated by an arousal. Nasal continuous positive airway pressure (CPAP) is the pri
- Oral morphine for cancer pain
Cochrane Systematic Reviews, 22-Apr-2016
This is the third updated version of a Cochrane review first published in Issue 4, 2003 of The Cochrane Library and first updated in 2007. Morphine has been used for many years to relieve pain. Oral morphine in either immediate release or modified release
- Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
Cochrane Systematic Reviews, 12-Dec-2012
This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD006921. DOI: 10.1002/14651858.CD006921.pub2).
- Oxcarbazepine add-on for drug-resistant partial epilepsy
Cochrane Systematic Reviews, 15-Nov-2016
Most people with epilepsy have a good prognosis and their seizures can be well controlled with the use of a single antiepileptic drug, but up to 30% develop refractory epilepsy, especially those with partial seizures. In this review we summarize the curre
- Oxcarbazepine in the maintenance treatment of bipolar disorder
Cochrane Systematic Reviews, 23-Jan-2008
Some studies have suggested that oxcarbazepine has a role in preventing episode recurrence in bipolar affective disorder. This review attempted to investigate the existing evidence from randomised controlled trials for its use in the maintenance treatment
- Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures
Cochrane Systematic Reviews, 7-Oct-2009
Partial onset seizures are often treated with the standard antiepileptic drug carbamazepine. Oxcarbazepine is a newer antiepileptic drug related to carbamazepine that is claimed to be better tolerated.
- Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
Cochrane Systematic Reviews, 23-Oct-2018
This is an updated version of the Cochrane Review previously published in 2013. This review is one in a series of Cochrane Reviews investigating pair-wise monotherapy comparisons.
- Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults
Cochrane Systematic Reviews, 30-Apr-2013
This is an updated version of the original Cochrane review published in Issue 11, 2010 (Derry 2010). Migraine is a common, disabling condition and a burden for the individual, health services and society. Many sufferers choose not to, or are unable to, se
- Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years
Cochrane Systematic Reviews, 9-Nov-2011
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterised by high levels of inattention, hyperactivity and impulsivity that are present before the age of seven years, seen in a range of situations, inconsistent with th
- Pergolide for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 13-Nov-2008
In later Parkinson's disease, long-term treatment with levodopa therapy is associated with the development of motor complications which include abnormal involuntary movements (dyskinesia) and a shortening response to each dose (wearing off phenomenon). Do
- Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 13-Nov-2008
Long-term levodopa therapy in Parkinson's disease is associated with the development of motor complications including abnormal involuntary movements and a shortening response to each dose (wearing off phenomenon). It is thought that dopamine agonists can
- Pharmacological interventions for epilepsy in people with intellectual disabilities
Cochrane Systematic Reviews, 3-Sep-2015
The prevalence of epilepsy among people with intellectual disabilities is much higher than in the general population. Seizures in this population are often complex and refractory to treatment and antiepileptic medication may have a profound effect upon be
- Pharmacological interventions for spasticity following spinal cord injury
Cochrane Systematic Reviews, 24-Apr-2000
Spasticity is a major health problem for patients with a spinal cord injury (SCI). It limits their mobility and affects their independence in activities of daily living (ADL) and work. Spasticity may also cause pain, loss of range of motion, contractures,
- Pharmacological management for agitation and aggression in people with acquired brain injury
Cochrane Systematic Reviews, 13-May-2008
Of the many psychiatric symptoms that may result from brain injury, agitation and/or aggression are often the most troublesome. It is therefore important to evaluate the efficacy of psychotropic medication used in its management.
- Pharmacological treatment for aphasia following stroke
Cochrane Systematic Reviews, 23-Oct-2001
Aphasia describes language impairment associated with a brain lesion.
